SCHEMBL7019295

SCHEMBL7019295

CCN(CC)CCN(C)C(=O)CC1CCCN(C(=O)c2ccc(OC)c(OC)c2)c2ccc(Cl)cc21

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SPTLC2 O15270 2/20 0.47
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
AVPR2 P30518 1/20 0.40
TP53 P04637 1/20 0.39
ALDH1A1 P00352 4/20 0.38
POLB P06746 1/20 0.38
CYP2C19 P33261 1/20 0.38
HPGD P15428 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NR3C1 P04150 1/20 0.37
KDM4E B2RXH2 1/20 0.37
F10 P00742 1/20 0.37
LMNA P02545 1/20 0.36
KDM2B Q8NHM5 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4684483 0.85 AVPR2 (0.46) SPTLC2AVPR2ALDH1A1HPGD
Hydrochloric Acid SCHEMBL7021837 0.85 AVPR2 (0.41) AVPR2ALDH1A1L3MBTL1
SCHEMBL7241445 0.82 AVPR2 (0.52) AVPR2
SCHEMBL7241507 0.80 AVPR2 (0.45) AVPR2
SCHEMBL4682873 0.79 AVPR2 (0.45) SPTLC2AVPR2ALDH1A1HPGD
SCHEMBL4685605 0.78 SPTLC2 (0.43) SPTLC2PDE4APDE4BPDE4CPDE4D
SCHEMBL7345395 0.76 SPTLC2 (0.47) SPTLC2PDE4APDE4BPDE4CPDE4D
SCHEMBL9088215 0.76 AVPR2 (0.54) AVPR2
SCHEMBL4685984 0.75 ALDH1A1 (0.46) SPTLC2TP53ALDH1A1HPGD
SCHEMBL4684981 0.75 AVPR2 (0.52) AVPR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0765314-B1 BENZOHETEROCYCLIC DERIVATIVES USEFUL AS VASOPRESSIN OR OXYTOCIN MODULATORS OTSUKA PHARMA CO LTD (JP) 2003-05-07 EP disclosed
EP-1221440-A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators Otsuka Pharmaceutical Company, Limited (JP) 2002-07-10 EP disclosed